•
Mar 31, 2023

Avidity Biosciences Q1 2023 Earnings Report

Total Revenue
$2.23M
Previous year: $1.8M
+24.4%
EPS
-$0.74
Previous year: -$0.71
+4.2%
R&D Expenses
$47.8M
G&A Expenses
$12.1M
Gross Profit
$1.15M
Previous year: $1.48M
-22.1%
Cash and Equivalents
$119M
Previous year: $139M
-14.8%
Free Cash Flow
-$50.8M
Previous year: -$30.3M
+67.4%
Total Assets
$614M
Previous year: $421M
+45.8%

Avidity Biosciences

Avidity Biosciences

Avidity Biosciences Revenue by Segment